Hiroyuki Motoshima
Overview
Explore the profile of Hiroyuki Motoshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murata Y, Haneda M, Miyakawa N, Nishida S, Kajihara N, Maeda S, et al.
Intern Med
. 2023 Jun;
63(3):425-431.
PMID: 37344441
A 52-year-old Japanese woman developed type 1 diabetes mellitus (type 1 DM) at 41 years old. She became complicated with Hashimoto's disease and showed swelling of both submandibular glands, which...
2.
Kondo T, Kitano S, Miyakawa N, Watanabe T, Goto R, Sato M, et al.
Intern Med
. 2021 May;
60(9):1433-1442.
PMID: 33952814
The gastrointestinal tract is considered an important endocrine organ for controlling glucose homeostasis via the production of incretins. A 21-year-old man emergently underwent total colectomy due to severe ulcerative colitis,...
3.
Kondo T, Miyakawa N, Kitano S, Watanabe T, Goto R, Suico M, et al.
Endocr Connect
. 2021 Apr;
10(5):521-533.
PMID: 33883285
Nonalcoholic fatty liver disease (NAFLD) is often accompanied by metabolic disorders such as metabolic syndrome and type 2 diabetes (T2DM). Heat shock response (HSR) is one of the most important...
4.
Morita Y, Senokuchi T, Yamada S, Wada T, Furusho T, Matsumura T, et al.
BMJ Open Diabetes Res Care
. 2020 Oct;
8(1).
PMID: 33087339
Introduction: Obesity-related insulin resistance is a widely accepted pathophysiological feature in type 2 diabetes. Systemic metabolism and immunity are closely related, and obesity represents impaired immune function that predisposes individuals...
5.
Yoshinaga A, Kajihara N, Kukidome D, Motoshima H, Matsumura T, Nishikawa T, et al.
Antioxid Redox Signal
. 2020 Aug;
34(16):1245-1259.
PMID: 32757614
Hypoglycemia is associated with increased reactive oxygen species (ROS) production and vascular events. We have previously reported that low-glucose (LG) conditions induce mitochondrial ROS (mtROS) production in aortic endothelial cells...
6.
Igata M, Yagi Y, Hanatani S, Sakaguchi M, Ishii N, Yoshinaga K, et al.
J Diabetes Investig
. 2020 Jul;
12(4):668-671.
PMID: 32706496
Dopamine receptor agonists are typically used to treat Parkinson's disease and certain pituitary tumors, such as prolactinoma or a growth hormone-producing tumor. A 53-year-old woman with a history of prolactinoma...
7.
Araki E, Araki H, Senokuchi T, Motoshima H
J Diabetes Investig
. 2020 Apr;
11(4):795-797.
PMID: 32232932
No abstract available.
8.
Nishida S, Matsumura T, Senokuchi T, Murakami-Nishida S, Ishii N, Morita Y, et al.
Biochem Biophys Res Commun
. 2020 Jan;
524(1):8-15.
PMID: 31964532
Background And Aims: Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to suppress atherosclerosis progression in atherosclerotic mouse models through unclear mechanisms. In this study, we investigated the effect of the...
9.
Murakami-Nishida S, Matsumura T, Senokuchi T, Ishii N, Kinoshita H, Yamada S, et al.
Atherosclerosis
. 2019 May;
286:30-39.
PMID: 31096071
Background And Aims: Local macrophage proliferation is linked to enhanced atherosclerosis progression. Our previous study found that troglitazone, a thiazolidinedione (TZD), suppressed oxidized low-density lipoprotein (Ox-LDL)-induced macrophage proliferation. However, its...
10.
Goto R, Kondo T, Ono K, Kitano S, Miyakawa N, Watanabe T, et al.
J Clin Med
. 2019 May;
8(5).
PMID: 31091693
Because the renin-angiotensin-aldosterone system influences glucose homeostasis, the mineralocorticoid receptor (MR) signal in pancreatic islets may regulate insulin response upon glucose load. Glucagon-like peptide-1 (GLP-1) production is stimulated by interleukin-6...